Article info

Download PDFPDF
Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB–IIB cervical cancer

Authors

  • Charlotte Maene University Hospital Leuven, Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Rawand Rokan Salihi University Hospital Leuven, Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Els Van Nieuwenhuysen University Hospital Leuven, Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Sileny N Han University Hospital Leuven, Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Nicole Concin Department of Gynaecology and Obstetrics, Innsbruck Medical Univeristy, Innsbruck, Austria PubMed articlesGoogle scholar articles
  • Ignace Vergote University Hospital Leuven, Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Ignace Vergote, University Hospital Leuven, Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, Katholieke Universiteit Leuven, Leuven 3000, Flanders, Belgium; ignace.vergote{at}uz.kuleuven.ac.be
View Full Text

Citation

Maene C, Salihi RR, Van Nieuwenhuysen E, et al
Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB–IIB cervical cancer

Publication history

  • Received January 26, 2021
  • Revision received March 26, 2021
  • Accepted March 31, 2021
  • First published April 15, 2021.
Online issue publication 
April 24, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.